Top

Published in:

01-06-2007 | Original Paper

Association of diabetes with mammographic breast density and breast cancer in the Minnesota breast cancer family study

Authors: Thomas A. Sellers, Leif E. Jensen, Robert A. Vierkant, Zachary S. Fredericksen, Kathleen R. Brandt, Anna R. Giuliano, Vernon S. Pankratz, James R. Cerhan, Celine M. Vachon

Published in: Cancer Causes & Control | Issue 5/2007

Abstract

Data from the Minnesota Breast Cancer Family Study cohort (n = 6,130 women) were used to examine the association of type II diabetes with mammographic percent density and incident breast cancer (BC). Exposures and outcomes were self-reported. The first set of analyses evaluated diabetes (DM) as a risk factor for breast cancer. A total of 403 women (6.6%) reported a diagnosis of type II diabetes and 333 women reported an incident breast cancer. Women who reported type II diabetes had an age-adjusted relative risk (RR) for breast cancer of 1.44 (95% CI 0.89–2.32) compared to those who did not. Adjustment for covariates strengthened the association (RR 1.61, 95% CI 0.98–2.62). Mammograms were retrieved on women over the age of 40 and percent density was estimated with a user-assisted thresholding program. Cross-sectional analyses revealed that mean levels of mammographic density were not statistically significantly different between diabetic and non-diabetic women. Results were similar within strata of menopausal status. Breast cancer cases with diabetes did not have a significantly higher percent density than cases without diabetes. Our findings suggest that breast cancer risk may be increased among women with type II diabetes, but that type II diabetes does not significantly influence mammographic breast density.

Michels KB, Solomon CG, Hu FB, Rosner BA, Hankinson SE, Colditz G et al (2003) Type 2 diabetes and subsequent incidence of breast cancer in the Nurses’ Health Study. Diabetes Care 26:1752–1758PubMedCrossRef

Adami HO, McLaughlin J, Ekbom A, Berne C, Silverman D, Hacker D et al (1991) Cancer risk in patients with diabetes mellitus. Cancer Causes Control 2:307–314PubMedCrossRef

Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159:1160–1167PubMedCrossRef

Franceschi S, la Vecchia C, Negri E, Parazzini F, Boyle P (1990) Breast cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer 26:781–785PubMedCrossRef

Baron JA, Weiderpass E, Newcomb PA, Stampfer M, Titus-Ernstoff L, Egan KM et al (2001) Metabolic disorders and breast cancer risk (United States). Cancer Causes Control 12:875–880PubMedCrossRef

Mink PJ, Shahar E, Rosamond WD, Alberg AJ, Folsom AR (2002) Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study. Am J Epidemiol 156:349–352PubMedCrossRef

O’Mara BA, Byers T, Schoenfeld E (1985) Diabetes mellitus and cancer risk: a multisite case-control study. J Chronic Dis 38:435–441PubMedCrossRef

Ragozzino M, Melton LJ, Chu CP, Palumbo PJ (1982) Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis 35:13–19PubMedCrossRef

Talamini R, Franceschi S, Favero A, Negri E, Parazzini F, La Vecchia C (1997) Selected medical conditions and risk of breast cancer. Br J Cancer 75:1699–1703PubMed

10.

Sellers TA, Sprafka JM, Gapstur SM, Rich SS, Potter JD, Ross JA, McGovern PG et al (1994) Does body fat distribution promote familial aggregation of adult onset diabetes mellitus and postmenopausal breast cancer? Epidemiology 5:102–108PubMedCrossRef

11.

Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B (2005) Diabetes mellitus and breast cancer. Lancet Oncol 6:103–111PubMedCrossRef

12.

Strickler HD, Wylie-Rosett J, Rohan T, Hoover DR, Smoller S, Burk RD et al (2001) The relation of type 2 diabetes and cancer. Diabetes Technol Ther 3:263–274PubMedCrossRef

13.

Sugumar A, Liu YC, Xia Q, Koh YS, Matsuo K (2004) Insulin-like growth factor (IGF)-I and IGF-binding protein 3 and the risk of premenopausal breast cancer: a meta-analysis of literature. Int J Cancer 111:293–297PubMedCrossRef

14.

Renehan AG, Zwahlen M, Minder C, O’Dwyer ST, Shalet SM, Egger M (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363:1346–1353PubMedCrossRef

15.

Fletcher O, Gibson L, Johnson N, Altmann DR, Holly JM, Ashworth A, Peto J, Silva Idos S (2005) Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review. Cancer Epidemiol Biomarkers Prev 14:2–19PubMed

16.

Li BD, Khosravi MJ, Berkel HJ, Diamandi A, Dayton MA, Smith M et al (2001) Free insulin-like growth factor-I and breast cancer risk. Int J Cancer 91:736–739PubMedCrossRef

17.

Toniolo P, Bruning PF, Akhmedkhanov A, Bonfrer JM, Koenig KL, Lukanova A et al (2000) Serum insulin-like growth factor-I and breast cancer. Int J Cancer 88:828–832PubMedCrossRef

18.

Krajcik RA, Borofsky ND, Massardo S, Orentreich N (2002) Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. Cancer Epidemiol Biomarkers Prev 11:1566–1573PubMed

19.

Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B et al (1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351:1393–1396PubMedCrossRef

20.

Schernhammer ES, Holly JM, Pollak MN, Hankinson SE (2005) Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14:699–704PubMedCrossRef

21.

Malin A, Dai Q, Yu H, Shu XO, Jin F, Gao YT et al (2004) Evaluation of the synergistic effect of insulin resistance and insulin-like growth factors on the risk of breast carcinoma. Cancer 100:694–700PubMedCrossRef

22.

Rinaldi S, Peeters PH, Berrino F, Dossus L, Biessy C, Olsen A et al (2006) IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 13:593–605PubMedCrossRef

23.

Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE (2006) Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II. Endocr Relat Cancer 13:583–592PubMedCrossRef

24.

Renehan AG, Harvie M, Howell A (2006) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on. Endocr Relat Cancer 13:273–278PubMedCrossRef

25.

Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ (1998) Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 7:1133–1144PubMed

26.

Whitehead J, Carlile T, Kopecky KJ, Thompson DJ, Gilbert FI, Present AJ et al (1985) The relationship between Wolfe’s classification of mammograms, accepted breast cancer risk factors, and the incidence of breast cancer. Am J Epidemiol 122:994–1006PubMed

27.

Bartow SA, Pathak DR, Mettler FA, Key CR, Pike MC (1995) Breast mammographic pattern: a concatenation of confounding and breast cancer risk factors. Am J Epidemiol 142:813–819PubMed

28.

Vachon CM, Kuni CC, Anderson K, Anderson VE, Sellers TA (2000) Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control, 11:653–662PubMedCrossRef

29.

Maskarinec G, Williams AE, Kaaks R (2003) A cross-sectional investigation of breast density and insulin-like growth factor I. Int J Cancer 107:991–996PubMedCrossRef

30.

Byrne C, Colditz GA, Willett WC, Speizer FE, Pollak M, Hankinson SE (2000) Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res 60:3744–3748PubMed

31.

Boyd NF, Dite GS, Stone J, Gunasekara A, English DR, McCredie MR et al (2002) Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 347:886–894PubMedCrossRef

32.

Berube S, Diorio C, Verhoek-Oftedahl W, Brisson J (2004) Vitamin D, calcium, and mammographic breast densities. Cancer Epidemiol Biomarkers Prev 13:1466–1472PubMed

33.

Diorio C, Pollak M, Byrne C, Masse B, Hebert-Croteau N, Yaffe M et al (2005) Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density. Cancer Epidemiol Biomarkers Prev 14:1065–1073PubMedCrossRef

34.

Guo YP, Martin LJ, Hanna W, Banerjee D, Miller N, Fishell E et al (2001) Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomarkers Prev 10:243–248PubMed

35.

Roubidoux MA, Kaur JS, Griffith KA, Sloan J, Wilson C, Novotny P et al (2003) Correlates of mammogram density in southwestern Native-American women. Cancer Epidemiol Biomarkers Prev 12:552–558PubMed

36.

Sellers TA, Anderson VE, Potter JD, Bartow SA, Chen PL, Everson L et al (1995) Epidemiologic and genetic follow-up study of 544 Minnesota breast cancer families: design and methods. Genetic Epidemiol 12:417–429CrossRef

37.

Sellers TA, King RA, Cerhan JR, Chen PL, Grabrick DM, Kushi LH et al (1999) Fifty-year follow-up of cancer incidence in a historical cohort of Minnesota breast cancer families. Cancer Epidemiol Biomarkers Prev 8:1051–1057PubMed

38.

Weaver TW, Kushi LH, McGovern PG, Potter JD, Rich SS, King RA et al (1996) Validation study of self-reported measures of fat distribution. Int J Obes Relat Metab Disord 20:644–650PubMed

39.

Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ (1994) The quantitative analysis of mammographic densities. Phys Med Biol 39:1629–1638PubMedCrossRef

40.

Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ (1996) Automated analysis of mammographic densities. Phys Med Biol 41:909–923PubMedCrossRef

41.

Hjalgrim H, Frisch M, Ekbom A, Kyvik KO, Melbye M, Green A (1997) Cancer and diabetes – a follow-up study of two population-based cohorts of diabetic patients. J Intern Med 241:471–475PubMedCrossRef

42.

Grabrick DM, Hartmann LC, Cerhan JR, Vierkant RA, Therneau TM, Vachon CM et al (2000) Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer. JAMA 284:1791–1798PubMedCrossRef

43.

Korn EL, Graubard BI, Midthune D (1997) Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 145:72–80PubMed

44.

Fisher LD, Lin DY (1999) Time-dependent covariates in the Cox proportional-hazards regression model. Annu Rev Public Health 20:145–157PubMedCrossRef

45.

Therneau TM, Grambsch PM (2000) Modeling survival data: extending the Cox model. Statistics for biology and health. Springer, New York

46.

Strange KS, Wilkinson D, Edin G, Emerman JT (2004) Mitogenic properties of insulin-like growth factors I and II, insulin-like growth factor binding protein-3 and epidermal growth factor on human breast stromal cells in primary culture. Breast Cancer Res Treat 84:77–84PubMedCrossRef

47.

Strange KS, Wilkinson D, Emerman JT (2002) Mitogenic properties of insulin-like growth factors I and II, insulin-like growth factor binding protein-3 and epidermal growth factor on human breast epithelial cells in primary culture. Breast Cancer Res Treat 75:203–212PubMedCrossRef

48.

Sandhu MS (2005) Insulin-like growth factor-I and risk of type 2 diabetes and coronary heart disease: molecular epidemiology. Endocr Dev 9:44–54PubMedCrossRef

49.

Dunger DB, Ong KK, Sandhu M (2003) Serum insulin-like growth factor-I levels and potential risk of type 2 diabetes. Horm Res 60(Suppl 3):131–135PubMedCrossRef

50.

Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H (1999) Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metab Res Rev 15:314–322PubMedCrossRef

51.

Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE (2006) Adult weight change and risk of postmenopausal breast cancer. JAMA 296:193–201PubMedCrossRef

52.

Harvie M, Howell A, Vierkant RA, Kumar N, Cerhan JR, Kelemen LE et al (2005) Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women’s health study. Cancer Epidemiol Biomarkers Prev 14:656–661PubMedCrossRef

Title: Association of diabetes with mammographic breast density and breast cancer in the Minnesota breast cancer family study
Authors: Thomas A. Sellers
Leif E. Jensen
Robert A. Vierkant
Zachary S. Fredericksen
Kathleen R. Brandt
Anna R. Giuliano
Vernon S. Pankratz
James R. Cerhan
Celine M. Vachon
Publication date: 01-06-2007
Publisher: Kluwer Academic Publishers
Published in: Cancer Causes & Control / Issue 5/2007
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-007-0128-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2007

Breastfeeding and risk of ovarian cancer in two prospective cohorts

History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study

Impact of a primary care intervention on smoking, drinking, diet, weight, sun exposure, and work risk in families with cancer experience

A systematic review of myeloid leukemias and occupational pesticide exposure

A comparison of the anatomic distribution of cutaneous melanoma in two populations with different levels of sunlight: the west of Scotland and Queensland, Australia 1982–2001

Scanning the horizon: What is the future of genome-wide association studies in accelerating discoveries in cancer etiology and prevention?

Keynote webinar | Spotlight on antibody–drug conjugates in cancer